Authors: WHITE EL BOWDON BJ SHANNON WM

Citation: El. White et al., SAFETY FACTORS INVOLVED IN THE EXTRACTION OF BIOLOGICALLY-ACTIVE PROTEINS FROM HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of virological methods, 70(1), 1998, pp. 113-115

Authors: QUENELLE DC KEITH KA DUNLEAVY KE TAYLOR BA BOWDON BJ BRAZIER AD MULLON CJP HARRIS RE ALLEN LB

Citation: Dc. Quenelle et al., EVALUATION OF ANTI-AIDS DRUGS IN CONVENTIONAL MICE IMPLANTED WITH A PERMEABLE MEMBRANE DEVICE CONTAINING HUMAN T-CELLS INFECTED WITH HIV, Antiviral research, 35(2), 1997, pp. 123-129

Authors: VINCE R KILAMA J PHAM PT BEERS SA BOWDON BJ KEITH KA PARKER WB

Citation: R. Vince et al., 6-SUBSTITUTED DERIVATIVES OF CARBOVIR - ANTI-HIV ACTIVITY, Nucleosides & nucleotides, 14(8), 1995, pp. 1703-1708

Authors: PARKER WB SHADDIX SC BOWDON BJ ROSE LM VINCE R SHANNON WM BENNETT LL

Citation: Wb. Parker et al., METABOLISM OF CARBOVIR, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, AND ITS EFFECTS ON CELLULAR-METABOLISM, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1004-1009